PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center study
PSMA-PET led to management changes in nearly one-third of post-prostatectomy recurrent PCa, notably affecting RT strategies and systemic therapy. Emerging evidence suggests that treatment intensification based on PSMA-PET findings may improve patient outcomes compared to de-intensified approaches. The impact on outcomes awaits validation from ongoing prospective randomized trials.
Authors
- Valeria Chiofalo
- Umberto Ricardi
- Erica Maria Cuffini
- M. Levis
- Cristiano Grossi
- S Grimaldi
- Guido ROVERA
- R. Parise
- Giuseppe Carlo Iorio (ORCID: https://orcid.org/0000-0003-1390-4191)
- V. Richetto
- Diego Bongiovanni
- Paolo Gontero
- F. Clot
- Silvia Morbelli
Institutions
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Fondazione Ricerca Molinette (IT)
- Department of Medical Sciences (BY)
- University of Turin (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fonc.2026.1764588
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00